DeepMed Research

UNIVERSITY OF ILLINOIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1859-01-01

Employees: 10K

Market Cap: -

Website: http://www.illinois.edu

Clinical Trials

Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults

Not Applicable

Completed

Conditions: Obese Older Adults
Mediterranean Diet
Cognition

Interventions: Behavioral: MedDiet

First Posted Date: 2017-04-26

Last Posted Date: 2021-04-08

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 180

Registration Number: NCT03129048

Locations: 🇺🇸
University Of Illinois at Chicago, Chicago, Illinois, United States

Child Development and Primary Care in Low Income Families

Not Applicable

Active, not recruiting

Conditions: Parenting
Development, Child

Interventions: Other: Child Safety Handout
Behavioral: Sit Down and Play

First Posted Date: 2017-04-24

Last Posted Date: 2025-01-17

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 60

Registration Number: NCT03126292

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes

Phase 2

Active, not recruiting

Conditions: Myelodysplastic Syndromes
Acute Myeloid Leukemia

Interventions: Drug: Fludarabine
Drug: Busulfan
Drug: ATG
Radiation: Total Marrow Irradiation
Procedure: Stem Cell Product Infusion
Drug: Tacrolimus
Drug: Methotrexate

First Posted Date: 2017-04-19

Last Posted Date: 2024-07-25

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 38

Registration Number: NCT03121014

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Resistance Exercise Training in Chronic Kidney Disease

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Behavioral: Resistance exercise training

First Posted Date: 2017-04-19

Last Posted Date: 2019-04-16

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 34

Registration Number: NCT03120416

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Phase 2

Recruiting

Conditions: Sickle Cell Disease

Interventions: Drug: ATG
Drug: fludarabine
Drug: cyclophosphamide
Radiation: Total body irradiation
Procedure: Stem cell infusion
Drug: Sirolimus
Drug: mycophenolate mofetil

First Posted Date: 2017-04-19

Last Posted Date: 2024-11-12

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 50

Registration Number: NCT03121001

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Randomization of Early Diabetes Screening Among Obese Pregnant Women.

Phase 3

Terminated

Conditions: Gestational Diabetes

Interventions: Drug: Screening for diabetes with 1-hour GCT and HbA1

First Posted Date: 2017-04-14

Last Posted Date: 2020-03-03

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 600

Registration Number: NCT03116009

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities

Not Applicable

Completed

Conditions: Hypertension

Interventions: Other: ED SBIRT-HTN
Other: PACHT-c

First Posted Date: 2017-03-28

Last Posted Date: 2020-04-16

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 150

Registration Number: NCT03093532

Feeding the Critically Ill During Phases of Altered Redox Status

Not Applicable

Completed

Conditions: Oxidative Stress
Systemic Inflammatory Response Syndrome
Acute Respiratory Distress Syndrome
Euthyroid Sick Syndromes

Interventions: Other: Jevity 1.5

First Posted Date: 2017-03-21

Last Posted Date: 2019-04-16

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 35

Registration Number: NCT03085615

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

Interactions Between Drug Effects and Environments II

Phase 4

Completed

Conditions: Substance-Related Disorders

Interventions: Behavioral: Paired
Drug: Stimulant or sedative
Drug: Placebo

First Posted Date: 2017-03-09

Last Posted Date: 2021-05-19

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 133

Registration Number: NCT03075501

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies

Phase 3

Terminated

Conditions: Focus: Prevent Preterm Delivery
Incidental Short Cervix at Mid-trimester

Interventions: Drug: Arabin Pessary

First Posted Date: 2017-02-14

Last Posted Date: 2020-08-05

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 57

Registration Number: NCT03052270

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy